These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4390487)

  • 21. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1980 Oct; 13(4):513-7. PubMed ID: 6107935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of nialamide, pargyline and tranylcypromine on the removal of amphetamine by the perfused liver.
    Trinker FR; Rand MJ
    J Pharm Pharmacol; 1970 Jul; 22(7):496-9. PubMed ID: 4395053
    [No Abstract]   [Full Text] [Related]  

  • 24. Body temperature responses in cats and rabbits to the monoamine oxidase inhibitor tranylcypromine.
    Feldberg W; Lotti VJ
    J Physiol; 1967 May; 190(1):203-20. PubMed ID: 6038022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors.
    Greeff K; Dènes B; Tawfik H
    Mod Probl Pharmacopsychiatry; 1983; 19():220-30. PubMed ID: 6408408
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 27. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT.
    TSAI TH; FLEMING WW
    Biochem Pharmacol; 1965 Mar; 14():369-71. PubMed ID: 14314337
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
    Norberg KA
    Acta Physiol Scand; 1965 Nov; 65(3):221-34. PubMed ID: 4379526
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A; Costa E
    Biochem Pharmacol; 1975 Sep; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated rats.
    Clarke DE
    Br J Pharmacol; 1970 Jan; 38(1):1-11. PubMed ID: 4391732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The degeneration contraction of a sympathetically innervated smooth muscle in the rat after reserpine, inhibition of monoamine oxidase or tyrosine hydroxylase.
    Lundberg D
    Acta Physiol Scand; 1970 Sep; 80(1):107-16. PubMed ID: 4394456
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS].
    HORNYKIEWICZ O
    Wien Klin Wochenschr; 1964 Apr; 76():289-93. PubMed ID: 14223504
    [No Abstract]   [Full Text] [Related]  

  • 35. Interactions of non-selective monoamine oxidase inhibitors, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E; Wozniak KM
    J Psychiatr Res; 1984; 18(2):191-203. PubMed ID: 6235366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcellular distribution of 5-hydroxytryptamine in rat brain during development: effect of drugs and fasting.
    Tissari AH; Raunu EM
    J Neurochem; 1975 Jun; 24(6):1143-50. PubMed ID: 1079237
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of phenylethylamine metabolism in vivo-Effect of antidepressants.
    Von Voigtlander PF; Losey EG
    Biochem Pharmacol; 1976 Jan; 25(2):217-8. PubMed ID: 1259787
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.